Comparing Regorafenib Combined With Envafolimab to Physician's Choice in Patients With Metastatic Gastrointestinal Stromal Tumors Harboring KIT Exon 17 Mutations Refractory to Standard Treatment

Clinical trial NCT07559864 · RECRUITING

Trial details

NCT number: NCT07559864
Sponsor: Jian Li
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

GIST - Gastrointestinal Stromal Tumor KIT Gene Mutation

Start date: 2025-07-14
Primary completion: 2027-06-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.